News

Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
Company on track to commence U.S. clinical studies in 2025 to support a De Novo application for FDA approvalTHE WOODLANDS, TX, April 08, 2025 ...
Yahoo Finance4d
JTC PLC (JTC.L)
As of 1:02:29 PM GMT+1. Market Open.
MarketWatch5d
Laila Maidan
Laila Maidan is a Tech and Investing reporter at MarketWatch. She covers the rapid developments in the sector along with actionable investment recommendations and deep dives into valuations.